These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34383334)

  • 1. Muscle architecture is associated with muscle fat replacement in Duchenne and Becker muscular dystrophies.
    Veeger TTJ; van Zwet EW; Al Mohamad D; Naarding KJ; van de Velde NM; Hooijmans MT; Webb AG; Niks EH; de Groot JH; Kan HE
    Muscle Nerve; 2021 Nov; 64(5):576-584. PubMed ID: 34383334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
    Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies.
    Spitali P; Hettne K; Tsonaka R; Charrout M; van den Bergen J; Koeks Z; Kan HE; Hooijmans MT; Roos A; Straub V; Muntoni F; Al-Khalili-Szigyarto C; Koel-Simmelink MJA; Teunissen CE; Lochmüller H; Niks EH; Aartsma-Rus A
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):715-726. PubMed ID: 29682908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patients.
    Wokke BH; Van Den Bergen JC; Hooijmans MT; Verschuuren JJ; Niks EH; Kan HE
    Muscle Nerve; 2016 Jan; 53(1):38-43. PubMed ID: 25847364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel biomarker of fibrofatty replacement in dystrophinopathies identified by integrating transcriptome, magnetic resonance imaging, and pathology data.
    Xie Z; Liu C; Sun C; Lu Y; Wu S; Liu Y; Wang Q; Wan Y; Wang Y; Yu M; Meng L; Deng J; Zhang W; Wang Z; Yang C; Yuan Y; Xie Z
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):98-111. PubMed ID: 38146684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients.
    Capitanio D; Moriggi M; Torretta E; Barbacini P; De Palma S; Viganò A; Lochmüller H; Muntoni F; Ferlini A; Mora M; Gelfi C
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):547-563. PubMed ID: 31991054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular dystrophy.
    Wokke BH; Hooijmans MT; van den Bergen JC; Webb AG; Verschuuren JJ; Kan HE
    NMR Biomed; 2014 Nov; 27(11):1371-7. PubMed ID: 25196814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies.
    Soblechero-Martín P; López-Martínez A; de la Puente-Ovejero L; Vallejo-Illarramendi A; Arechavala-Gomeza V
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):711-723. PubMed ID: 33999469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-uniform muscle fat replacement along the proximodistal axis in Duchenne muscular dystrophy.
    Hooijmans MT; Niks EH; Burakiewicz J; Anastasopoulos C; van den Berg SI; van Zwet E; Webb AG; Verschuuren JJGM; Kan HE
    Neuromuscul Disord; 2017 May; 27(5):458-464. PubMed ID: 28302391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
    Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
    JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utilisation of multimodal quantitative magnetic resonance imaging in investigating muscular damage in Duchenne muscular dystrophy: a study on the association between gluteal muscle groups and motor function.
    Song Y; Xu HY; Xu K; Guo YK; Xie LJ; Peng F; Xu R; Fu H; Yuan WF; Zhou ZQ; Cheng BC; Fu C; Zhou H; Cai XT; Li XS
    Pediatr Radiol; 2023 Jul; 53(8):1648-1658. PubMed ID: 36892624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin-associated protein abnormalities in dystrophin-deficient muscle fibers from symptomatic and asymptomatic Duchenne/Becker muscular dystrophy carriers.
    Di Blasi C; Morandi L; Barresi R; Blasevich F; Cornelio F; Mora M
    Acta Neuropathol; 1996 Oct; 92(4):369-77. PubMed ID: 8891069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients.
    Anand A; Prabhakar S; Kaul D
    Neurol India; 1999 Sep; 47(3):218-23. PubMed ID: 10514583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study.
    Batra A; Lott DJ; Willcocks R; Forbes SC; Triplett W; Dastgir J; Yun P; Reghan Foley A; Bönnemann CG; Vandenborne K; Walter GA
    J Neuromuscul Dis; 2020; 7(4):407-417. PubMed ID: 32538860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-tensor magnetic resonance imaging captures increased skeletal muscle fibre diameters in Becker muscular dystrophy.
    Cameron D; Abbassi-Daloii T; Heezen LGM; van de Velde NM; Koeks Z; Veeger TTJ; Hooijmans MT; El Abdellaoui S; van Duinen SG; Verschuuren JJGM; van Putten M; Aartsma-Rus A; Raz V; Spitali P; Niks EH; Kan HE
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1546-1557. PubMed ID: 37127427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
    Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.